SUSTIVA
Total Payments
$35,407
Transactions
1,687
Doctors
603
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $32.68 | 2 | 2 |
| 2018 | $26.08 | 2 | 2 |
| 2017 | $35,348 | 1,683 | 599 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,226 | 1,673 | 71.2% |
| Consulting Fee | $8,145 | 9 | 23.0% |
| Space rental or facility fees (teaching hospital only) | $2,000 | 2 | 5.6% |
| Education | $35.65 | 3 | 0.1% |
Ad
Manufacturing Companies
- E.R. Squibb & Sons, L.L.C. $35,407
Product Information
- Type Drug
- Total Payments $35,407
- Total Doctors 603
- Transactions 1,687
About SUSTIVA
SUSTIVA is a drug associated with $35,407 in payments to 603 healthcare providers, recorded across 1,687 transactions in the CMS Open Payments database. The primary manufacturer is E.R. Squibb & Sons, L.L.C..
Payment data is available from 2017 to 2019. In 2019, $32.68 was paid across 2 transactions to 2 doctors.
The most common payment nature for SUSTIVA is "Food and Beverage" ($25,226, 71.2% of total).